Outcome of Endovascular Treatment in Symptomatic Intracranial Vascular Stenosis.
- Author:
Dae Chul SUH
1
;
Sang Joon KIM
;
Duk Hee LEE
;
Won KIM
;
Choog Gon CHOI
;
Jeong Hyun LEE
;
Hyun Jeong KIM
;
Sun Uck KWON
;
Jong Sung KIM
Author Information
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords: Cerebral blood vessels, transluminal angioplasty; Stents and prostheses
- MeSH: Adult; Aged; *Angioplasty; Anticoagulants/therapeutic use; Chi-Square Distribution; Female; Humans; Intracranial Arteriosclerosis/radiography/*therapy; Male; Middle Aged; Radiography, Interventional; Recurrence; Research Support, Non-U.S. Gov't; *Stents; Treatment Outcome
- From:Korean Journal of Radiology 2005;6(1):1-7
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: The outcome evaluation for the revascularization of intracranial vascular stenoses has not been fully described due to the highly technical nature of the procedure. We report here on the early and late clinical outcomes of angioplasty and/or stenting of symptomatic severe intracranial vascular stenoses at a single institute. MATERIALS AND METHODS: Since 1995, we have treated 35 patients with symptomatic intracranial vascular stenosis (more than 70% stenosis, mean stenosis: 78.6%+/-6.2%). An gioplasty (n = 19) was performed for the horizontal segment of the middle cerebral artery (M1) (n = 16) and the basilar artery (BA) (n = 1), the intradural vertebral artery (VA) (n = 1), and the cavernous internal carotid artery (ICA) (n = 1). Stenting (n = 16) was performed for the cavernous or petrous ICAs (n = 9), the intradural VA (n = 3), BA (n = 2), and M1 (n = 2) artery. We assessed the angiographic success (defined as residual stenosis < 50%) rate, the periprocedural complications during the 30-day periprocedural period, the symptomatic recurrence and restenosis during a mean 22-month follow-up (FU) period. The Kaplan-Meier estimate of the cumulative event-free rate of the major cerebrovascular events, i.e. death, stroke or restenosis, was also done. RESULTS: Angiographic success was achieved in 97% of our patients (34/35). There were four procedure-related complications (11%) including a death and a minor stroke. During the mean 22-month FU, the asymptomatic restenosis rate was 9% and the symptomatic restenosis rate was 6% in the target lesion and 9% in all the vascular territories. The Kaplan-Meier estimate was 70.6% (95% confidence interval = 46.5-94.7) after 33 months of FU. CONCLUSION: In addition to a high angiographic success rate and an acceptable periprocedural complication rate, intracranial angioplasty and/or stenting revealed a relatively low symptomatic recurrence rate. Hemorrhage is a rare, but the physician must aware that potentially fatal periprocedural complications can occur.
